Anti-programmed celldeath receptor 1 (PD-1)/ programmed death ligand 1 (PD-L1) antibodies (pembrolizumaband nivolumab) are ICIs that block the interaction between PD-1 and PD-L1, promotinga T-cell response against tumor cells(10). The gene discussed is CD274; the disease is neoplasm.